Skip to main content
Clinical Trials/DRKS00017845
DRKS00017845
Recruiting
Not Applicable

Prospective registry study to record the diagnosis and treatment of diabetic sensorimotor polyneuropathy - PREDIP

WÖRWAG Pharma GmbH & Co. KG0 sites1,100 target enrollmentOctober 10, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G63.2
Sponsor
WÖRWAG Pharma GmbH & Co. KG
Enrollment
1100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with diagnosed polyneuropathy in diabetes mellitus or prediabetes.
  • Patients who are present at the time of enrollment at diagnosis or follow up on polyneuropathy.
  • Written consent to study participation is available.
  • Age \= 18 years.

Exclusion Criteria

  • Neuropathies that are, in the opinion of the physician,non\-diabetes related.
  • Patients with confirmed other painful illnesses that focus on non\-neuropathic complaints (eg, spinal disorders, orthopedic or rheumatologic diseases).
  • Patients with existing consumptive diseases or in a palliative situation.
  • Participation or planned participation in an interventional study on neuropathy or neuropathic pain at the time of inclusion.

Outcomes

Primary Outcomes

Not specified

Similar Trials